Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026 and Mar 2026.
- Largest single sale: $14.9M (205,608 shares) of Ionis Pharmaceuticals Inc on Mar 16, 2026. Filing
- Last sale before this period: Sep 30, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | Director | Jul 18, 2024 | Sep 14, 2026 |
| Ionis Pharmaceuticals Inc (IONS) | EVP, Finance & CFO | Jan 3, 2013 | Mar 18, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Mar 17, 2026, Ionis Pharmaceuticals Inc: sold 10,172 shares for $745K, under a disclosed plan. 1 filing: 1
- Mar 16, 2026, Ionis Pharmaceuticals Inc: sold 215,048 shares for $15.6M, under a disclosed plan; 174,999 shares acquired by exercising options. 1 filing: 1
- Jan 30, 2026, Ionis Pharmaceuticals Inc: sold 6,988 shares for $582K, no plan disclosed. 1 filing: 1
- Jan 29, 2026, Ionis Pharmaceuticals Inc: 13,562 shares awarded. 1 filing: 1
- Jan 16, 2026, Ionis Pharmaceuticals Inc: sold 12,922 shares for $972K, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.